AlphaMaven AlphaMaven

Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Reported by Healthexec
Dec 2, 2024· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • The Private Equity Stakeholder Project (PESP) has publicly opposed Marc Rowan's potential nomination as Treasury Secretary, citing serious conflict-of-interest concerns given his role as CEO of Apollo Global Management and the position's regulatory oversight of the private equity industry.
  • • Apollo Global Management owns approximately 220 hospitals across 36 states through subsidiaries Lifepoint Health and ScionHealth, with PESP asserting that these assets carry heavy debt loads and have reduced operating costs and charity care to service obligations.
  • • A Treasury Secretary appointment would grant Rowan direct influence over a $24 trillion private equity market while his firm faces heightened regulatory scrutiny on healthcare and retail investments, potentially violating antitrust considerations.
  • • Rowan owns approximately 6% of Apollo Global Management and would likely need to divest his stake to address conflict-of-interest requirements if confirmed to the Cabinet position.
  • • PESP, a nonprofit organization that regularly publishes reports detailing private equity influence on social infrastructure, has framed the nomination risk as creating regulatory capture dynamics in healthcare oversight.
Summary
The Private Equity Stakeholder Project has issued a formal statement opposing the potential appointment of Marc Rowan, CEO of Apollo Global Management, to the position of Treasury Secretary in the incoming Trump administration. While Rowan has not been officially nominated, Business Insider and other outlets have reported that he is actively lobbying for a Cabinet role and has scheduled a meeting with President-elect Donald Trump.

PESP's core objection centers on an irreconcilable conflict of interest. The Treasury Secretary position carries extensive oversight authority over the private equity industry, creating a problematic dynamic whereby Rowan could influence regulatory treatment of his own firm. According to PESP's statement, "Rowan's consideration for Treasury Secretary raises concern given the extensive oversight the position has over the private equity industry and the high level of scrutiny already placed on his firm's healthcare and retail investments."

The watchdog group specifically highlighted Apollo Global Management's substantial healthcare footprint. The firm controls approximately 220 hospitals across 36 states through two subsidiaries: Lifepoint Health and ScionHealth. PESP argues that under Apollo's ownership, these hospital operators have accumulated significant debt burdens and subsequently reduced operating costs and charitable care provision to manage debt servicing obligations. The organization contends that these assets are now subject to elevated credit risk and may be approaching antitrust concerns through recent acquisition activity.

The potential appointment carries material market implications. Control of the Treasury Secretary position would grant Rowan direct influence over a $24 trillion private equity market. Additionally, if confirmed, Rowan would likely be required to divest his approximately 6% stake in Apollo Global Management to address federal conflict-of-interest requirements.

PESP, which conducts ongoing research analyzing private equity's influence on critical social infrastructure, has positioned this advocacy statement within its broader mandate to scrutinize sector dynamics and regulatory capture risks in healthcare and other essential services.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Healthexec Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary